17

General Information


DRACP ID  DRACP00164

Peptide Name   17

Sequence  YXGFM

Sequence Length  5

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
HEp-2 Human papillomavirus-related endocervical adenocarcinoma Carcinoma 1% inhibition at 10-6 M, 10.1% inhibition at 10-5 M, 16.8% inhibition at 10-4 M, 36.1% inhibition at 10-3 M MTT assay 72 h 1
HeLa Human papillomavirus-related endocervical adenocarcinoma Carcinoma 4.9% inhibition at 10-6 M, 10.2% inhibition at 10-5 M, 13.3% inhibition at 10-4 M, 28% inhibition at 10-3 M MTT assay 72 h 1
HBL Melanoma Carcinoma 0.8% inhibition at 10-6 M, 1.4% inhibition at 10-5 M, 2.4% inhibition at 10-4 M, 18.3% inhibition at 10-3 M MTT assay 72 h 1
HT-29 Colon adenocarcinoma Carcinoma 3.3% inhibition at 10-6 M, 11% inhibition at 10-5 M, 7.9% inhibition at 10-4 M, 23.7% inhibition at 10-3 M MTT assay 72 h 1
SW620 Colon adenocarcinoma Carcinoma 12.2% inhibition at 10-6 M, 15.5% inhibition at 10-5 M, 24.7% inhibition at 10-4 M, 29% inhibition at 10-3 M MTT assay 72 h 1
CaCo-2 Colon adenocarcinoma Carcinoma 3% inhibition at 10-6 M, 8.4% inhibition at 10-5 M, 18.5% inhibition at 10-4 M, 10.6% inhibition at 10-3 M MTT assay 72 h 1
MCF-7 Invasive breast carcinoma of no special type Carcinoma 22.8% inhibition at 10-3 M MTT assay 72 h 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  lead to apoptosis

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  X=Cαα -dialkylated glycine (Aaa1 )

Chiral  L



Physicochemical Information


Formula  C25H30N4O5S

Absent amino acids  ACDEHIKLNPQRSTVW

Common amino acids  FGMYX

Mass  68012

Pl  6.09

Basic residues  0

Acidic residues  0

Hydrophobic residues  1

Net charge  0

Boman Index  613

Hydrophobicity  60

Aliphatic Index  0

Half Life 
  /

Extinction Coefficient cystines  1490

Absorbance 280nm  372.5

Polar residues  2

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 16722632

Title  Tumor-cell-targeted methionine-enkephalin analogues containing unnatural amino acids: design, synthesis, and in vitro antitumor activity

Doi 10.1021/jm051026

Year  +2006

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.